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Quantitative Systems Biology to decipher design principles of a
dynamic cell cycle network: the “Maximum Allowable
mammalian Trade–Off–Weight” (MAmTOW)
Matteo Barberis1 and Paul Verbruggen1
Network complexity is required to lend cellular processes ﬂexibility to respond timely to a variety of dynamic signals, while
simultaneously warranting robustness to protect cellular integrity against perturbations. The cell cycle serves as a paradigm for such
processes; it maintains its frequency and temporal structure (although these may differ among cell types) under the former, but
accelerates under the latter. Cell cycle molecules act together in time and in different cellular compartments to execute cell type-
speciﬁc programs. Strikingly, the timing at which molecular switches occur is controlled by abundance and stoichiometry of
multiple proteins within complexes. However, traditional methods that investigate one effector at a time are insufﬁcient to
understand how modulation of protein complex dynamics at cell cycle transitions shapes responsiveness, yet preserving
robustness. To overcome this shortcoming, we propose a multidisciplinary approach to gain a systems-level understanding of
quantitative cell cycle dynamics in mammalian cells from a new perspective. By suggesting advanced experimental technologies
and dedicated modeling approaches, we present innovative strategies (i) to measure absolute protein concentration in vivo, and (ii)
to determine how protein dosage, e.g., altered protein abundance, and spatial (de)regulation may affect timing and robustness of
phase transitions. We describe a method that we name “Maximum Allowable mammalian Trade–Off–Weight” (MAmTOW), which
may be realized to determine the upper limit of gene copy numbers in mammalian cells. These aspects, not covered by current
systems biology approaches, are essential requirements to generate precise computational models and identify (sub)network-
centered nodes underlying a plethora of pathological conditions.
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INTRODUCTION
Computational systems analysis can reveal hitherto unknown
features of individual components of a biological process and,
importantly, identify emerging properties underlying the process
itself. While initial systems biology approaches were, often by
necessity, reductionist and theoretical, they nowadays encompass
entire molecular networks which increasingly rely on quantitative
biological data. Molecular biology classically tends to be
interpreted by phenomenological descriptions of biological
processes, and subsequent analysis of their individual constitu-
ents. Therefore, an (r)evolution was needed directed towards the
integration of biological data in computer models, which
predictions may be not always straightforwardly interpretable
through intuition.1
The realization that, amongst others, stochastic gene transcrip-
tion may considerably impact on individual cell behavior2 has
sparked a great interest in systemic approaches able to capture
individual cell dynamics rather than representing the behavior of
the average population. Experimental biology has thus shifted its
focus from population-based qualitative analyses to single-cell-
based quantitative analyses. This shift partially includes an
emphasis on experimental methods such as microscopy techni-
ques and ﬂow cytometry, and the development of high
throughput single-cell sequencing rather than biochemical
techniques, such as Western blotting and Polymerase Chain
Reaction (PCR), which are traditionally keyed to population
analyses. Within this scenario, quantitative ﬂuorescence time-
lapse microscopy has helped greatly to elucidate many unknown
protein properties which cannot be captured by in vitro, static
analyses such as traditional biochemistry approaches. For
example, the levels of the tumor suppressor p53, the “guardian
of the genome”, have been shown to vary between cells and
substantially oscillate depending on the cellular stress3, and its
function to be compromised by incorrect cytoplasmic localiza-
tion.4 Intriguingly, p53 oscillation amplitude and frequency
depend on its subcellular localization, as well as association with
other protein factors which exhibit an oscillatory behavior, such as
circadian clock factors.5 Furthermore, the Nuclear transcription
Factor kappaB (NF-ĸB)–which regulates expression of genes
involved in inﬂammation and cell survival–shows robust nucleo/
cytoplasmic oscillations upon stimulation by different doses of
Tumor Necrosis Factor alpha (TNFα).6 Strikingly, these studies
demonstrate that the frequency of spatial and temporal oscilla-
tions determines the nature of the resulting response and, in turn,
depends on the amount and magnitude of upstream regulators.
The sheer size of the data generated by these methodologies, in
which many individual cells may be followed not only statically
but also in time, quickly becomes overwhelming. Thus, its
integration into intelligible concepts often supersedes one’s
intuition. To fully understand the data cohesion and analyze
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them to draw meaningful conclusions and to generate new
hypotheses, it is crucial to integrate them into in silico
mathematical models. These models have the ability to analyze
molecular networks as a whole, precisely assigning the contribu-
tion of their components simultaneously. Such iteration between
computation and experimentation, however, still requires the
need to cleverly map a biological process under investigation with
its underlying details, if the modeling outcome is indeed to be
comprehensive. This approach is particularly relevant for those
processes, such as the eukaryotic cell cycle, for which complexity
is required to lend ﬂexibility to respond timely to a variety of
dynamic signals, while simultaneously warranting robustness to
protect cellular integrity against perturbations.7
Here we propose how to integrate new and sophisticated
experimental methodologies and deﬁnite computational frame-
works to: 1) Map the mammalian cell cycle process, 2) Measure
quantitatively and simultaneously the systems-level data that are
required for the process to function dynamically, and 3) Model the
process in silico. By a systemic exploration of quantitative
properties (protein dosage) of cell cycle regulators, as well as
their spatiotemporal dynamics (protein localization in time,
therefore dosage distribution among cellular compartments), we
will ﬁrst provide a rationale for the relevance of these parameters
for cell cycle timing, exempliﬁed by the regulation of the Cyclin-
dependent kinase (Cdk) inhibitor p27Kip1 (in the following
indicated as p27), which controls timely phase transitions.8
Subsequently, we will review modern strategies to determine
parameters experimentally, ultimately integrating them into
computer models. We envision the creation of predictive, in silico
models able to pinpoint how a change in the stoichiometry of
molecular regulators, including protein complexes, and their
spatiotemporal dynamics impacts on the timing of cell cycle
transitions, thereby cell cycle robustness. These models may be
employed to examine whether perturbations, e.g., reduction and
increase in complexity, impact on both robustness and respon-
siveness of cell cycle dynamics.
Current computational models of cell cycle networks often rely
on concentration thresholds arbitrarily chosen, which are required
to switch from one cell cycle phase to another. Furthermore,
they do not include protein localization or dosage variability.
The overall strategy that we propose may explore systematically
permissible protein ranges by an innovative, quantitative
method that we name “Maximum Allowable mammalian
Trade–Off–Weight” (MAmTOW), and predict the variations that
may lead to loss of robustness. The evaluation of the extent to
which removal of regulatory loops impinges on both robustness
and responsiveness, constitutes a new way of exploring the effects
that protein abundance, localization and complex formation have
on cell integrity.
Relevance of protein localization on cell cycle timing
Multi-level regulation of the cell cycle that includes response to
stimulatory inputs, control of phase transition and adaptation to
perturbations, requires cooperation of molecules interconnected
in a dynamic network that warrants ﬂexibility and robustness.
These molecules act together in time and in different cellular
compartments to execute the cell cycle program. While this
program is unidirectional, multiple interactions and reactions
occur simultaneously to mediate a timely succession of events. A
property that still remains poorly understood is the cellular
compartmentalization and, consequently, the change in localiza-
tion of cell cycle molecules–in particular proteins–in time. We
hypothesize that availability of proteins in the compartment
where they excert their function modulates cell cycle timing; that
is, correct protein localization is critical for cell cycle robustness.
The cell cycle is a prominent example of a biological process
where many proteins follow a tightly regulated scheme over time
(Fig. 1): synthesis and degradation, complex formation and
dissociation, localization are parameters used to constrain cell
cycle models. On the other hand, in these models protein
localization is often approximated by a concerted decrease of
protein availability in mathematical terms, akin to protein
degradation. However, the consequences for the timing of cell
cycle progression may differ dramatically between protein
degradation and re-localization. For instance, the function of
p53 may be compromised by its incorrect cytoplasmic localization,
without any difference in net protein expression levels.4, 9
Similarly, untimely or aberrant cytoplasmic translocation of p27
may cause cell cycle disruption10, 11, in addition to relieving
nuclear cyclin/Cdk kinase complexes from p27-mediated inhibi-
tion. In the cytoplasm, p27 interacts with non-Cdk proteins to
ensure correct centrosome ampliﬁcation and cytokinesis.12, 13
Even though levels of p27 are severely reduced after the G1/S
transition, its localization re-wires the interactions it can establish
in either nucleus or cytoplasm, effectively impacting on cell cycle
temporal dynamics. Cyclin E/Cdk2 and cyclinA/Cdk2 complexes
modulating G1 and S phases, respectively, are targets of p27-
mediated inhibition and have a predominant localization in the
nucleus. It has been reported that both cyclins E and A can also
localize to the centrosomes.14 This localization proved to be
important for a correct centrosome duplication and for initiation
of DNA replication.15, 16 Canonical interactors of cyclins, Cdk2 and
p27 have not been found at the centrosomes, suggesting that the
interaction landscape of cyclins A and E differs depending on their
cellular compartment.17 Strikingly, their inappropriate localization
is detrimental in a number of cancers.18
These data imply that proteins may have functions outside their
cognate compartment, and that computer models should
appropriately include localization rather than emulating degrada-
tion simply by reducing to zero protein concentrations. As it
becomes evident for the cyclins, native or spurious functions
outside the canonical compartment may feedback on their
availability inside the canonical compartment. Evidently, misloca-
lization impacts on protein availability at a deﬁnite timing during
cell cycle progression, resulting in altered cellular dynamics and,
ultimately, impacting on cell integrity. Importantly, precise
dynamics of protein complexes, which are regulated by spatio-
temporal localization and dosage of their components19, 20, shall
be also considered. In conclusion, to comprehend how timely cell
cycle transitions are achieved, accurate computational approaches
shall include protein spatiotemporal dynamics.21 This may allow
for the development of predictive models able to address the
effect of protein mislocalization, e.g., changes in concentration
and relative abundance, and its impact on the interaction
landscape in the speciﬁc cellular compartments.
Visualization of protein localization through time
Tracking protein localization has been possible since the
introduction of the Green Fluorescent Protein (GFP) and its
variants as tags to visualize proteins in single cells and in real-time
by microscopy.22 Although nowadays tracking of ﬂuorescent cell
cycle protein derivatives is technically simple, it is challenging to
do so while maintaining native protein expression levels and
function, which rely on the chromosomal context of the encoding
gene (i.e., introns, exons and proximity to (un)identiﬁed regulatory
sequences). The conservation of these features requires the
application of a more complex genetic engineering approach,
by which a protein of interest can be visualized whilst ensuring
that the spatial localization of its gene on the chromatin and its
chromosomal context remain unaltered. The recently introduced
CRISPR/Cas9 system allows editing genomes without altering the
genetic context23, and offers a suitable platform for both gene-
tagging and modulation of transcriptional regulation.24–26 In
parallel, methods have been developed that separate the protein
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of interest from the ﬂuorescent reporter, thus preserving its native
conformation and function. Recently, a method has been
developed that introduces a gene for a ﬂuorescent protein within
the same transcription unit as the gene of interest.27 A small
sequence encoding a viral cleavage peptide was placed between
the two genes, in order to separate the two encoded proteins
post-translationally. The approach succeeded in retaining both
native protein expression levels as well as providing a ratiometric
readout to allow quantitative protein determination in single cells
in vivo.27
A convenient way to visualize cell cycle progression is to utilize
the variety of ﬂuorescent reporters available to determine the
precise timing of phase transitions. The Fluorescent Ubiquitination-
based Cell Cycle Indicator (FUCCI) was developed based on the
proteasomal turnover of ﬂuorescently-tagged cell cycle proteins.28
By monitoring Cdt1-RFP and Geminin-GFP, which regulate
alternatively activation (also called licensing) of replication origins
to initiate DNA synthesis29, cell cycle dyamics can be monitored
over time (Supplementary Fig. S1). Protein levels of Geminin and
Cdt1 oscillate inversely: in G1 phase, Geminin is degraded and
Cdt1 accumulates, thus promoting assembly of the pre-
Replication Complex (pre-RC) at the replication origins (Cdt1-RFP
is visualized as red ﬂuorescence within the nuclei); in S/G2/M
phases, Cdt1 is degraded and Geminin accumulates, thus
inhibiting the formation of the pre-RC (Geminin-GFP is visualized
as green ﬂuorescence within the nuclei). Furthermore, the G0/G1
transition from quiescient to proliferating cells was monitored by
using a fusion protein between the ﬂuorescent protein mVenus
Fig. 1 Schematic representation of processes occurring throughout cell cycle progression, exempliﬁed by the role of the cyclin-dependent
kinase inhibitor p27Kip1 (p27). a In quiescent cells, p27 accumulates and inactivates cyclin E/Cdk2 complexes–deputed to promote DNA
replication at the G1/S transition-by sequestering them in a 1:1 stoichiometry and blocking their kinase activity (Supplementary References
1,2). b Mitogenic stimulation of quiescent cells leads to nuclear export of p27 mediated by cyclin D2 (Supplementary Reference 3) and the
nuclear export protein CRM1 (not visualized) (Supplementary Reference 4). c Export of p27 is coincidental with its phosphorylation on Ser10
(Supplementary Reference 5) by KIS (Supplementary Reference 6) and possibly PKB/Akt (Supplementary Reference 7) kinases. d Upon
cytoplasmic translocation, p27 is ubiquitylated and degraded through interaction with KPC ubiquitin ligase complexes (not visualized),
reducing p27 protein content in both nuclear and cytoplasmic compartments through export and by degradation, respectively
(Supplementary Reference 8). e Nuclear p27 is reduced further during the G0/G1 transition through its direct phosphorylation on Thr157
by cytoplasmic Akt kinase, preventing both de novo produced and exported p27 from (re)entering the nucleus (Supplementary References 9–
11). Cytoplasmic translocation, degradation and p27 exclusion from the nucleus lead to a ﬁrst wave of active cyclin/Cdk kinase complexes that
allow entry of cells in G1 phase. During this phase, p27 regulation is altered: f activation of Cdk2 leads to phosphorylation of p27 on Thr187
and g recognition by the SCF(Skp2) ubiquitin ligase complex, which is followed by rapid degradation of p27 in the nucleus (Supplementary
References 1,12). h This process leads to release of the inhibition of cyclin E/Cdk2 complexes and progression into S phase. i During S phase,
Cdk2 continues to phosphorylate p27 on Thr187 and, in turn, SCF(Skp2) keeps p27 at low levels in the nucleus (Supplementary References
1,4,13–15)
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and a Cdk-binding deﬁcient p27 (p27K−) protein30, inhibitor of the
cyclin/Cdk kinase activity and conserved in eukaryotes31, 32, in
combination with the FUCCI system.
This method provides an effective way to easily separate cell
cycle phases and measure the timing of phase transitions.
However, it requires engineered cell lines while simultaneously
reducing the usability of ﬂuorescent tags in the chosen experi-
mental setup. The cell cycle proteins used as markers for cell cycle
transitions may not be completely inert, potentially changing the
cycling behavior or the temporal phase distribution in the
investigated cell type. Despite these potential challenges, the
FUCCI system has become a leading system for cell cycle tracking
in imaging experiments not only in cells but also in organisms33,
and it has been used to screen the inﬂuence of anticancer drugs
on cell cycle dynamics.34 Altogether, protein localization can be
investigated by a combination of the FUCCI system, ﬂuorescently-
labeled proteins and ﬂuorescence microscopy. Thus, the integra-
tion of modern genetic engineering and protein tracking
technology enables spatiotemporal mapping of cell cycle protein
dynamics.
Altering spatiotemporal dynamics in the mammalian system
Experimental investigation of the impact that protein spatiotem-
poral dynamics may have on cellular processes and their
molecular switches has been hampered by the continuous
shortcomings of classic and modern techniques. For example, it
remains difﬁcult to dynamically alter protein localization, thereby
protein dosage, on-demand. The use of proteins modiﬁed to
contain in their sequence Nuclear Localization and Nuclear Export
Signals (NLS and NES, respectively) to control localization are well
known. However, they often lack temporal dynamics and
regulation. Only recently strategies have been devised that enable
the real-time activation of NLS and NES by simple light
illumination. Several of such light-induced systems have been
described35, 36 responding to different wavelengths of light. Many
of these systems have some drawbacks, such as the requirement
for external components to allow photoactivation, irreversible
promoter activation by the light, or high background activation
under non-induced conditions.
Recently, a more practical light-inducible system was intro-
duced, based on optogenetic tools that enable controlling with
light the nuclear import and export of tagged proteins in both
budding yeast and mammalian cells.37, 38 Speciﬁcally, a Light-
Inducible, fully reversible and genetically encoded Nuclear
localization Signal (LINuS) was developed.37 This is based on a
small tag, the Light-Oxygen-Voltage (LOV) domain, derived from
the Avena sativa phototropin 1 protein (AsLOV2), which can be
fused to a NLS. Illumination by blue light triggers a conformational
change of the AsLOV2 domain and the consequent exposure of
the NLS, previously masked from the nuclear import machinery in
the dark state, allowing it to be translocated selectively into the
nucleus37 (Supplementary Fig. S2a). The NLS was subsequently
replaced by a NES to enable nuclear export, a variant named
Light-inducible nuclear EXport sYstem (LEXY)38 (Supplementary
Fig. S2b). These systems were shown to function for transcription
factor import37 into, and export38 out, of the nucleus. By
mediating light-induced import of Cdk1, mitosis was induced in
mammalian cells; this process requires a timely nuclear transloca-
tion of the cyclin B1/Cdk1 complex to the nucleus, which
determines the commitment to mitosis.39 By demonstrating the
applicability of the light-inducible system as proof of principle to
investigate cell cycle control, this technique may be employed to a
wide-range of cellular processes that require a timely activation
upon translocation of pivotal proteins. Furthermore, it holds
promises not only for on-demand, real-time control over protein
localization, but also for single-cell localization studies (Supple-
mentary Fig. S2c).
Quantiﬁcation of protein dosage
An argument in the (re)construction of multi-protein networks in
silico is their ability to validate as well as predict the outcome of a
multitude of biological experiments, especially when molecule
concentrations are measured. In fact, these values serve as model
parameters in computational models. For convenience, protein
concentrations used in these models are often derived from
biochemical determinations of average molecule numbers per
cell.40, 41 These data are collected in PaxDB, a comprehensive
Protein Abundance Database, which contains the publicly
available experimental data of whole genome protein abundance
averages across organisms and tissues, ranging from the budding
yeast Saccharomyces cerevisiae to Zea mays to Homo sapiens.42
While the datasets of absolute protein concentrations are often
incomplete, to date computational models have shown that
multiple parameter settings may enable them to produce
oscillating protein concentrations.43 This oscillatory behavior
triggers cellular events, and is typically reproduced by the core
machinery of eukaryotic cell cycle models, guaranteeing progres-
sion through the various phases after particular components, i.e.,
the mitotic cyclins, reach a deﬁnite threshold.44 However, if this
threshold is not reached, a simulated cell cycle event does not
occur.
In order to generate accurate models and compute their
robustness, it is desired to elaborate further on the experimental
technologies currently available, which should be tailored to
precisely quantify protein concentrations as well as cell-to-cell and
intracellular spatiotemporal variability. Although absolute protein
concentrations are difﬁcult to measure experimentally, a new
technique, named Protein Quantitation Ratioing (PQR), has been
recently developed to measure the stoichiometric ratio between a
GFP (or potentially any other ﬂuorescent) reporter and a protein of
interest during protein translation in single cells in vivo27
(Supplementary Fig. S3). As a result, the ﬂuorescence intensity is
proportional to the molecule number of the protein in the cell.
Experimental and in silico evidence on individual signaling
pathways suggests that the fold change of protein dosage rather
than absolute protein levels may determine a cellular response.45,
46 Kitano and colleagues have developed further on this line,
addressing protein dosage elegantly by determining upper47, 48
and lower49 expression limits of cell cycle proteins in budding
yeast and in the ﬁssion yeast Schizosaccharomyces pombe.50
Strikingly, their ﬁndings indicated that neither the fold change nor
the absolute concentration increase of the investigated proteins
were leading for a protein’s upper expression limit, but rather their
stoichiometric balance in dimeric protein complexes. Thus, we
envision that an imbalanced protein dosage may disturb the
stoichiometry within multiprotein complexes that are responsible
for the passage through phase transitions. This imbalance
ultimately would destroy the network robustness, resulting in a
perturbed cell cycling, thereby in a reduced cellular viability.51, 52
This would also occur because changes in the stoichiometry
within multiprotein complexes does result not only from changes
in protein dosage, but also from an altered protein localization.
Availability of the empirically determined absolute concentra-
tion of a protein enables estimation of the relative expression of
its partner within a multimeric complex. However, this information
may be not obtained when only the variability of a protein
through time–derived from ﬂuorescently tagged-protein
dynamics by ﬂuorescence microscope – is known. That is, absolute
spatiotemporal concentration data measured for a large panel of
proteins in a similar system shall also yield information about
protein dosage. Hitherto, the most efﬁcient system to measure
protein concentrations in single living cells is offered by the
Fluorescence Correlation Spectroscopy (FCS) technique, which
enables determination of the absolute concentration of ﬂuores-
cent (bio)molecules by measuring ﬂuctuation of the ﬂuorescent
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intensity of a molecule in a given and ﬁxed volume53, 54
(Supplementary Fig. S4a). Several FCS-related techniques exist
that may be suitable to measure protein concentrations in cellular
compartments, migration speeds over membraneous structures,
and quantify protein complex formation. Through a pinhole only a
small volume of the sample, called confocal volume, is monitored.
Fluorescent particles ﬂuoresce whenever they pass through this
volume. By sampling the ﬂuctuation intensity as ﬂuorescent
particles travel in and out of the confocal volume at ﬁxed time
intervals, an autocorrelation plot is generated (Supplementary
Fig. S4a). This plot yields precise information about the average
number of ﬂuorescent particles and average diffusion times,
ultimately determining protein concentrations. For optimal
sensitivity FCS requires molecule concentrations to be in the
nanomolar to picomolar range, which makes this technique ideally
suited for ﬂuorescent proteins in living cells.
An extension of the FCS technique is called Fluorescence Cross-
Correlation Spectroscopy (FCCS), and it is employed to measure
the diffusion of multiple ﬂuorescent molecules simultaneously
(Supplementary Fig. S4b). Measurements of intensity ﬂuctuations
in the confocal volume of each ﬂuorescent molecule allow for the
determination of complex formation and of the fraction(s) of
complexed and non-complexed molecules. Thus, by selectively
targeting cellular compartments, such as nucleus or cytoplasm,
FCS measurements combined with conventional confocal micro-
scopy imaging provide information about complex formation
between two selected ﬂuorescent molecules, also measuring their
spatiotemporal dynamics. Interestingly, recent developments
allow for a full automation of FCS/FCCS in living cells with
simultaneous confocal imaging, high-throughput characterization
of a large number of proteins, and time-resolved characterization
of protein complex dynamics throughout an entire cell cycle.55
In summary, FCS and its variants require great care in
instrumental setup and calibration54, but they offer great promises
to determine biological variations in time and space of individual
proteins and complex formation. These data may then be
converted to kinetic parameters, which represent an input for
detailed computational models.
ENGINEERING MAMMALIAN CELLS TO PRECISELY DETERMINE
PROTEIN DOSAGE
As outlined earlier, it may be hypothesized that alteration of the
protein dosage impinges on both cell cycle timing and robustness.
Cell cycle robustness may be compromised by out-of-boundaries
protein expression, and its violation may be not identical
quantitatively among various proteins and cell types. As a
consequence, we propose that a compromised robustness due
to an altered expression of a cell cycle protein may be balanced by
simultaneously altering the expression of one of its partner within
a protein complex. This may be particular relevant for those
complexes that are responsible for biochemical switches at cell
cycle transitions. Considering the likelihood of this scenario, the
importance to quantify the expression limit of individual cell cycle
proteins, and to determine how its changes affect cell cycle timing
and robustness, becomes evident. The precise stoichiometry of
proteins within complexes can be integrated together in new and/
or existing in silico models of cell cycle control, which would then
be able to examine how gene dosage–through their effects on
multiprotein complex stoichiometry–may impact on both robust-
ness and responsiveness of cell cycle dynamics.
To determine the impact of protein dosage and localization on
cell cycle dynamics is challenging, due to the limited experimental
toolset available that allows for a quantitative, incremental
variability of these parameters in vivo. In fact, systematic control
of protein abundance in mammalian cells is limited by the
currently available experimental techniques to artiﬁcially and
dynamically modulate the amount of gene copy numbers.
Conversely, in both budding and ﬁssion yeasts, a dedicated
system named genetic Tug–Of–War (gTOW) has been developed
to determine the maximum dosage of proteins that a cell is
allowed to express yet being viable.47, 48, 50 In this approach, a
transcription unit of choice is cloned into a yeast expression
plasmid, and an artiﬁcial increase of the plasmid copy number per
cell is achieved by a selection marker. Practically, a leucine-
deﬁcient yeast strain is transformed with a plasmid carrying a
gene of interest and a gene relieving the leucine-deﬁciency
(leu2d). The capacity of the cells to grow on a leucine-deﬁcient
medium is linearly proportional to the expression of the leu2d
gene, giving yeast bearing many plasmids (thereby, many gene
copies) a growth advantage. Expression of the gene of interest,
however, may limit the maximum plasmid copy number when the
gene product is toxic upon its overexpression (Fig. 2a). Hence,
growing the yeast strain in a leucine-deﬁcient medium will lead to
a gTOW game where the two genes are at opposite ends of the
rope. This enables a precise determination of the highest copy
number of a given gene at which a cell still thrives. Strikingly, the
ceiling of expression differs markedly among genes. The yeast
gTOW system cannot be adapted to the mammalian system due
to the limitation represented by the selection marker to increase
the plasmid copy number.
In this section, by elaborating on the yeast gTOW system, we
explore the possibility to perform experiments yielding to
comparable data in mammalian cells. Through the availability of
modern techniques, such as the CRISPR/Cas9 technology, we
propose how the limit of protein dosage in mammalian cells may
be determined, and modulated, quantitatively. We envision the
development of strategies to create cell lines carrying a synthetic
cassette, which allows for a measurable and tunable expression of
a protein of interest.
Measuring the upper limits of protein expression in mammalian
cells
One of the key advantages of the transient gTOW system is that it
does not require the generation of speciﬁcally engineered yeast
strains for every protein that is to be investigated. Quite on the
contrary, the system relies on the runaway replication of episomes
independent of the host chromosome. For fast screening of a vast
amount of proteins, a transient system presents a versatile and
cost-effective option. Transfection of mammalian cell lines with a
transient, plasmid-based, system carrying an expression cassette
consisting of a gene of interest (for our scope, a cell cycle gene
would be the target gene) expressed under the control of a
promoter of choice, offers an equally fast and versatile system
depending on the desired level of expression. Variability in
expression is controlled through the amount of plasmids
transfected and the promoter that is selected for expression. For
example, a switchable tetracycline-inducible promoter may be
used to control the (over)expression (Fig. 2b). The cassette
contains a GFP reporter gene controlled by a constitutively active
promoter, preferably yielding low, but measurable protein
expression. In an experimental setup, the critical parameters that
determine protein expression ranges (promoter strength, cell line
transfection regime, optimum dosage of doxycycline/tetracycline)
are optimized. If a too high-potentially lethal-amount of the gene
product may be expressed, cells may undergo apoptosis, whereas
cells expressing a tolerable gene copy number, thereby protein
amounts, are viable and analyzed (Fig. 2c). GFP serves as a readout
for the amount of transfected DNA. Speciﬁcally, a linear correlation
is expected between GFP copies and the levels of a target protein,
whereas no correlation is expected in a construct lacking the
target gene but carrying GFP under a constitutive (non-induced)
promoter (Fig. 2d).
As indicated, tetracycline inducibility allows for an exact
determination of the experimental startpoint. After optimizing
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the appropriate experimental parameters, the maximum expres-
sion limit can be determined by measuring the maximum GFP
levels, hence the maximum relative plasmid copy number, by
ﬂuorescence microscopy and/or ﬂow cytometry. These results may
be compared to immunoﬂuorescent staining of the protein of
interest to validate the linearity between GFP signal and protein
dosage (Fig. 2c). However, whereas immunoﬂuorescence is
capable of protein dosage quantiﬁcation41, it cannot be used
easily to compare relative plasmid presence among different
proteins of interest. Therefore, measurements of GFP intensity
would be preferred as, after calibration, these allow to compare
protein dosage between samples (as they should reﬂect the
relative plasmid copy number akin to the determination of
plasmid copy number in yeast). By comparing the ﬂuorescence
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levels of induced samples and non-induced controls, the cut-off
relative plasmid copy number, hence the expression range of the
protein of interest allowed by the cell, may be determined. The
advantages of this method are multifold: (i) it is relatively fast and
fully transferable between cell lines, thus enabling the comparison
of different cell types, (ii) it relies exclusively on transient
transfection, and (iii) it allows for an easy co-expression of
multiple cell cycle proteins at the same time and in the same
experiment. After optimizing the experimental parameters, the
data derived are expected to be similar to those obtained from
gTOW experiments.
A non-native tetracycline expression unit and its variants have
been successfully employed in recent studies to control gene
expression in mammalian cells, which also carry an inducible
target gene coupled to a reporter56, 57 or that additionally respond
to a light-switchable transactivator.58 Interestingly, the
tetracycline-inducible system has been also utilized to control
cell cycle fate, speciﬁcally to suppress malignant growth and
induce apoptosis in cancer cells.59
MAmTOW: a CRISPR/Cas9-based gene expression system
A complementary strategy to measure gene dosage may be
envisioned taking advantage of the CRISPR/Cas9 technology23. It
has enabled not only directed knockout of genes in cells of various
backgrounds, but also gene or gene-promoter-replacements.
Contrarily to techniques that rely on random integration, the
CRISPR/Cas9 technology allows for a high degree of control by
allowing site-directed modiﬁcation of genomes. Thus, it is
expected to yield more reliable data, due to the fact that artefacts
due to spurious and/or gene-disruptive integrations shall be more
controllable as compared to other genetic engineering strategies.
As gene placement may have a substantial impact on transcription
dynamics, it offers advantages such as retroviral transduction or
transfection. By making use of CRISPR/Cas9, here we conceive an
innovative molecular methodology, which we coin as “Maximum
Allowable mammalian Trade–Off–Weight” (MAmTOW). This meth-
odology uniquely describes the functioning of a synthetic cassette
integrated into the genome of mammalian cell lines, which
replaces the endogeneous promoter of a target gene to allow for
its tunable expression and quantiﬁcation (once again, for our
scope, a cell cycle gene would be the target gene). Integration of
gene cassettes is less versatile as compared to a transient
transfection; however, the extra burden is a trade-off for quality,
as CRISPR/Cas9-engineered cell lines are expected to exhibit a
native-like behavior as compared to cells transiently transfected
with plasmid DNA.
A replacement of the two alleles of the reporter (cell cycle) gene
through CRISPR/Cas9 is shown in Fig. 3a. The entire cassette may
consist of: (i) a tetracyclin repressor (TetR unit), encoding a
bacterial repressor of the TET resistance gene, controlled by the
weak mouse phosphoglycerate kinase 1 promoter (PGK), (ii) a
reporter gene unit, encoding GFP or another suitable ﬂuorescent
protein, controlled by both the native, endogenous promoter
(Pend) of the gene of interest and a tetracycline-inducible
promoter, consisting of (iii) a strong cytomegalovirus promoter
(PCMV) preceding several copies–typically six or seven
56, 58 –of a
Tet-operator sequence (TetO). The TetR unit is continuously
produced by placing a constituvely active promoter (PGK) to the
3′-end of the ﬂuorescent reporter gene, to prevent target gene
transcription under non-inducing conditions (Fig. 3a). The cassette
may be followed by a transcription unit constituted by the
endogenous target gene bearing its native promoter Pend. To
prevent polymerase read-through transcription, the ﬂuorescent
reporter cassette and the endogenous target gene cassette should
be placed in reverse orientation relative to each other.
Both ﬂuorescent reporter and target genes are regulated by
identical control elements. To ensure a reliable and robust, non-
leaky induction of both genes, the number of TetO copies may
need to be optimized so that, in absence of tetracycline, PCMV is
repressed but both the target gene and the ﬂuorescent reporter
gene are transcribed normally. Upon addition of tetracycline (or
the more stable doxocycline analog), (over)expression may be
induced for both target and reporter genes, and a linear
correlation between these should be veriﬁed by either ﬂuores-
cence microscopy or ﬂow cytometry (Fig. 3a). By dose-response
analysis, the upper expression limit of any target gene may be
determined in presence of tetracycline. As with the gTOW
methodology and the transient (over)expression of genes
described above, the upper level of gene expression may be
measured and serves as a readout for the expression ceiling of a
target gene with relation to cell viability. In fact, the maximally
allowable dosage of a deﬁnite cell cycle regulator may impact on
the proliferative capacity, thereby on the cellular robustness. It is
conceivable that, in a non-induced scenario, transcription from the
native promoter of some target gene might be quenched by the
TetR elements. If this would occur, cells with single-allele
replacements may be selected to ensure presence of the protein
of interest (albeit at a lower level) while retaining inducibility.
A methodology recently developed, the Protein Quantitation
Ratioing, may be employed to determine quantitatively a
stoichiometric ratio between the ﬂuorescent protein reporter
and the target protein in vivo.27 Insertion of a tag, a Protein
Quantitation Reporter (PQR), between the ﬂuorescent reporter
gene and the target gene, allows for co-transcription and co-
translation of both genes, obviating the need for a separate
transcription module for the reporter gene (Fig. 3b). After
translation the inserted PQR sequence leads to its own removal
by interfering with polypeptide elongation, effectively leading to
Fig. 2 Cloning strategies to explore the upper limit of protein expression in mammalian cells by transient transfection methods. a The
transient system as proposed by Kitano and colleagues in the budding yeast Saccharomyces cerevisiae (see text for details). A GFP reporter is
used as a quantitative readout of relative plasmid copy number, and it can be used to determine the upper limits of target gene expression.
When the upper limit is reached, yeast cells will not be viable and a cut-off in ﬂuorescent signal is measured. b The simplest example of a
transient system for mammalian cells that may be used to determine upper protein expression limits. A plasmid bearing a target gene
(visualized in red) driven by its native promoter is transfected into a cell line. The expression level may be boosted by using a switchable
tetracycline-inducible (tet-inducible) promoter, which requires a cell line expressing the tet-repressor. By varying the amount of transfected
plasmid, expression level of the target gene may be regulated. Similarly to the system shown in a, cells that contain a too high number of
plasmid copies–thus, protein amounts beyond the viable expression limit–will not survive. Relative protein expression upper limits may be
determined by immunostaining, and comparison with non-transfected cells. c Elaborated version of the approach in b, where quantiﬁcation is
achieved by a ﬂuorescent reporter (e.g., GFP). A cassette containing the tet-repressor may be inserted to allow for an inducible protein
expression by using a tet-inducible promoter. In cells expressing the tet-repressor, or when another promoter is chosen, this cassette is
dispensable. The signal obtained from the ﬂuorescent reporter shall be proportional to the target gene expression, and may be used as a
readout for relative plasmid copy number, thereby protein expression. This system is independent from antibody staining. d Control
experiment of c, where the target gene is lacking. In this construct, the GFP signal should show no correlation with the target protein
expression. The upper limit of plasmid copies may also be determined by the allowed upper level of GFP expression that preserves cell
viability, thus setting the range for measurements
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Fig. 3 Maximum Allowable mammalian Trade–Off–Weight (MAmTOW) methodology to explore the upper limit of protein expression in
mammalian cells by stable integration via CRISPR/Cas9. a Through CRISPR/Cas9 the gene cassette (gray background) is integrated in front of
the target gene on both gene’s alleles. The cassette consists of (from left to right): a tet-repressor (TetR) under the control of the PGK promoter;
a ﬂuorescent reporter gene (e.g., GFP) controlled by the endogenous promoter of the target gene (Pend); a cytomegalovirus promoter (PCMV)
controlled by a Tet-operator unit (TetO), which is repeated seven times; and an identical Tet-operator unit in the sense-direction controlling a
PCMV promoter. The target gene (visualized in red, with introns indicated in gray) is intact and in its native context. Under non-induced
conditions, both reporter and target genes are transcribed according to the target gene’s native regime, while TetR is constitutively
transcribed. When tetracycline is added, TetR units are removed from the Tet-operator activating PCMV, and a proportional boost of
transcription of both reporter and target genes occurs. By determining cell viability in the presence of increasing tetracycline levels, the upper
limit of protein expression relative to non-induced conditions may be determined. b In an alternative scenario, the target gene is modiﬁed on
both gene’s alleles to be fused in frame with the ﬂuorescent reporter gene and a protein quantitation ratioing (PQR) domain upstream. The
translated polyprotein is cleaved by the PQR domain, resulting in a stoichiometric ratio between reporter and target proteins. c In addition to
a double-allele replacement assumed in a and b, also single-allele replacements may occur. These can be identiﬁed by the level of
ﬂuorescence associated to the reporter protein. In case the strategies in a and b hinders native gene transcription of the target gene under
non-induced conditions, cell lines may be selected that bear only single-allele integrations (assuming a diploid target cell line). In the gene
cassette used for this strategy, one allele is intact, while the other one carries the cassette shown in a (gray background) upstream of the
target gene. The placement is such that the modiﬁed allele is completely controlled by tetracycline induction
Systems-level quantitative cell cycle dynamics
M Barberis and P Verbruggen
8
npj Systems Biology and Applications (2017)  26 Published in partnership with the Systems Biology Institute
its excision and separation from the ﬂuorescent reporter and the
target protein. Since the PQR sequence serves as a “yoke”, both
ﬂuorescent reporter and target protein are now present in an
equimolar ratio. Therefore, the intensity of the ﬂuorescence
reporter is directly proportional to, and a measure of, the amount
of the target protein.
As the CMV promoter (PCMV) and the TetO cassette are in close
proximity to the endogeneous promoter of the target gene, it
cannot be ruled out that under non-induced conditions a
modulation of the target gene transcription may occur. Thus,
the optimum amount of TetO and the optimal proximity between
PCMV and the endogeneous promoters (Pend) may be determined
empirically; however, this may be cumbersome and, timewise,
costly. As the CRISPR/Cas9 technology allows for precise genome
engineering, cell clones may be selected (assuming a mammalian
cell carrying a diploid set of chromosomes) that carries the
MAmTOW engineered cassette on only one allele, instead of two.
An example of such a case is shown in Fig. 3c. One of the alleles
carries the wild type transcription unit of the target gene, whereas
the second allele is replaced by the regulatory cassette (it does not
alter the target gene sequence or composition). In the latter, the
endogenous promoter of the target gene is removed, thus this is
subjected to regulation by only the introduced tetracycline-
inducible cassette. Clones carrying mono-allelic replacements may
be selected by cell-sorting when using a ﬂuorescent reporter (Fig.
3c, lower panel). The selected mono-allelic clones exhibit wild type
behavior when no tetracycline is added (albeit gene dosage may
be halved), whereas addition of tetracycline leads to activation the
second allele and gene (over)expression.
MONITORING CELL CYCLE ROBUSTNESS THROUGH SYSTEMS
BIOLOGY
The proposed MAmTOW methodology represents a bridge
between classic single-cell analysis techniques, such as ﬂow
cytometry, and modern techniques relying on quantitative (high-
throughput) microscopy of CRISPR/Cas9-engineered cells. Direc-
ted gene replacement and gene manipulation can selectively alter
protein dosage, leading to possible changes in spatial protein
distribution; ﬂow cytometry and microscopy can be used to
monitor their effects on DNA content, allowing for protein
visualization, thus providing information on timely molecular
switches in cellular signaling. These switches are pivotal to control
cell fate, such as the ones that govern cell cycle progression,
where phase transitions are governed by modulation of the
stoichiometry of activators and inhibitors that exploit their
function within multi-protein complexes.
To understand how these transitions are regulated at a systems
level by the balance between activator and inhibitor molecules,
may reveal possible disease scenarios where protein dosage,
kinetics and/or localization may be misregulated. That is, protein
dosage, as well as localization are critical determinants of timely
and ordered cell cycle transitions. However, an altered protein
abundance or localization may impinge on the correct temporal
dynamics, thus altering the capacity of the cell cycle to retain
functionality against perturbations, thereby compromising cellular
robustness. In both budding and ﬁssion yeasts it was shown that
the upper limit of protein expression differs substantially between
cell cycle proteins, in some cases without affecting cell viability.48–50
This result directly implies that cell cycle robustness against
dosage is not identical for all molecules. Strikingly, the range of
protein dosage allowed is not static, but it is dependent on the
presence and, more speciﬁcally, the stoichiometry of the
interactors. For some proteins, the dosage limit allowed can be
increased by simultaneous overexpression of their interactor,
suggesting that stoichiometry of protein complexes may be a
crucial factor to maintain cell cycle robustness. Similar conclusions
were drawn for another biological oscillator, the circadian clock.
Speciﬁcally, in the mammalian circadian clock the stoichiometry
between the CLOCK-BMAL1 (activator) and PER-CRY (inhibitor)
protein complexes is crucial to maintain rhythm generation, thus
the robustness of circadian rhythms.60 Thus, the proposed
MAmTOW methodology may be generalized to also study
circadian rhythms.
To investigate robustness of the cell cycle network at a systems
level, integration of high-quality molecular interaction maps,
which include localization of components, with sophisticated
computer models is of vital importance. Computer models of cell
cycle regulation can yield viable predictions on cell cycle
robustness by varying dosage, which can be veriﬁed experimen-
tally.47, 61, 62 Furthermore, recurring and new network motifs at
the basis of system’s robustness may be identiﬁed.63–67 Therefore,
models generated on the basis of molecular interaction maps may
be simulated to mimic behavior of molecules and protein
complexes at phase transitions, pinpointing to (i) the precise
timing at which they function, and to (ii) the regulatory networks
they establish with the surrounding molecules in different cellular
compartments. Computationally, these models may include
various exit codes that indicate whether and why an error in the
previous iteration of the cell cycle simulation occurs.48 These exit
codes can be used to determine whether the simulation algorithm
should simulate progressive rounds of cell division, or if it should
stop because the simulated cell has encountered a problem, e.g.,
incorrect ordering of temporal events, impossibility to trigger one
of the checkpoints, numerical integration problems, etc. These
error codes are related to the dynamics at a given moment that
the model produces in terms of relative amplitudes and timing of
the molecular species being simulated.
Modeling of cell cycle regulation has a long tradition, and kinetic
models for the cell cycle in yeasts are particularly advanced.40, 61, 68
However, in this organism, alternative approaches such as
qualitative modeling (also called Boolean models) have been
employed to simulate cell cycle dynamics67, 69–71, also examining
the timing robustness of the process with respect to checkpoint
conditions.72 By comparison, fewer models exist that simulate
the mammalian cell cycle21, 73–76, for which the availability of
quantitative data about protein concentrations, localization and
kinetics is still a challenge. To model in detail dynamics of the
mammalian cell cycle control, reconstruction of a complete
molecular interaction map shall incorporate theoretically informa-
tion regarding localization, dosage, post-translational modiﬁca-
tions, and complex formation. The complexity of this map as
compared to the one of budding yeast62 may be reduced at the
level of phase transitions, such as G1/S or G2/M, in order for both
computer models and quantitative measurements to be manage-
able.77 By incorporating protein dosage as a function of time and
localization, the temporal formation of protein complexes may be
investigated with a detailed resolution. Again using the cyclin/Cdk
inhibitor p27 as an example, we exemplify below the relevance of
the interplay between dosage and timing in the context of cancer.
In this scenario, the crucial tuning of p27 abundance and
dynamics required for the correct progression throughout the
successive cell cycle phases breaks down.
p27 localization and dosage: timer to safeguard cellular
proliferation
The temporal distribution of p27 is strictly regulated, exhibiting
substantial ﬂuctuation of p27 abundance and spatial dynamics
over time. p27-mediated inhibition of Cdk2 prevents an untimely
entry into S phase; contrarily, untimely p27-mediated Cdk-
inhibition in S/G2 phases would lead to a failure of DNA synthesis,
resulting in harmful, multiple rounds of DNA replication. For this
reason, p27 is degraded timely, before the onset of cells into S
phase, preventing unwanted Cdk2 inhibition.78 This evidence
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illustrates the need for a strict spatiotemporal regulation of p27
throughout cell cycle progression.
Early studies on p27 knockout mice showed that this Cdk
inhibitor has a profound impact on organism and tissue
development, with its absence leading to an increased body size
and selective organ hyperplasia.79–81 The proliferative capacity of
quiescent cells, such as neurons, appeared to be unaltered,
whereas the proliferative capacity of immune cells was enhanced,
proportionally to the body size, highlighting important cell and
tissue-dependent speciﬁcity of p27 expression.79 The absence of
p27 did not lead to an increase in spontaneous tumors; however,
exposure of p27 nullizygous and heterozygous mice to gamma-
irradiation or chemical carcinogens exhibited a predisposition to
tumors in multiple tissues.80 p27 appears to safeguard cells
against harmful insults, thus functioning as a tumor suppressor in
mice. Furthermore, tumor suppressor activity of p27 was found to
be dependent on its gene dosage.80 This role was further
supported by investigating the phenotype of mice lacking Skp2,
a component of an ubiquitin ligase that is part of the ubiquitin-
proteasome pathway, which controls the ﬂuctuations of p27
levels.82 Besides displaying a decrease in body weight due to
increased p27 levels, these mice exhibit abnormal numbers of
centrosomes; this phenomenon may be attributed to the presence
of p27, as in Skp2−/−/p27−/− mice centrosome abnormalities were
much less pronounced.83, 84
p27 has been implicated as a prognostic factor for a number of
tumors, as reduced p27 levels have been observed in cancers of
the upper gastrointestinal tract, skin, glioma, sarcoma, and in
haematopoietic and epithelial malignancies.85 However, a clear
molecular mechanism is yet to be elucidated. Only recently the
puzzle was partly solved, by showing that p27 serves as a
safeguard tumor suppressor in malignancies where the axis pRB/
p53, responsible for most anti-tumor mechanisms, is lacking.86
Although in these tumors p27 is unable to prevent S phase onset,
it can inhibit cell division and, potentially, centrosome over-
replication. This ﬁnding may explain the recurrent association of
p27 with cancer severity, but also the ambiguity of p27 role in
cancer as a function of dosage, localization and presence of other
tumor suppressors. This evidence, together with the fact that a
compromised compartmentalization, in particular an increase in
its cytoplasmic localization87, can result in oncogenic functions of
p27, indicates that this inhibitor may function as an intracellular
timer at both G1/S and G2/M transitions as well as at cell division,
where it modulates the centrosome number.11, 12 However,
despite the substantial number of studies aiming to elucidate the
canonical (Cdk-dependent) and non-canonical (Cdk-indepen-
dent)88, 89 roles of p27, it still remains to be elucidated how its
localization and dosage distribute through, and affect, cell cycle
network dynamics.
As a dynamic regulator exhibiting ﬂuctuation of absolute levels
and localization throughout the cell cycle, p27 is an ideal
candidate to explore cell cycle robustness. Therefore, we extend
our ideas on the presented MAmTOW methodology and propose
a strategy to dynamically modulate p27 localization by a light-
inducible system, analyzing the phenotypic consequences. In this
variant of the MAmTOW methodology, a fusion between the
target gene CDKNB1 coding for p27 and a ﬂuorescent marker (in
this speciﬁc case being mCherry) is extended to insert in its C-
terminal region the aforementioned Light-inducible nuclear
EXport sYstem (LEXY).38 Using LEXY, illumination by blue light
enables the forced nuclear export of p27, thus allowing to
investigate–through a changed localization–alteration of cellular
properties such as timing at division, centrosome and chromo-
some numbers, with the latter reﬂecting the ploidy status of a cell
(Fig. 4a). Strikingly, quantiﬁcation of gene dosage may be realized
to scale up the MAmTOW technology to high-throughput
ﬂuorescence microscopy (Fig. 4b), by which dosage (i) of a single
target protein such as p27 (Fig. 4b, left panel), (ii) of a cellular
property such as centrosome number (Fig. 4b, middle panel), and
(iii) of two proteins forming protein complexes (Fig. 4b, right
panel) may be quantiﬁed in single cells.
Systems biology blueprint to uncover cell cycle functions in
systems diseases
Cell cycle control is distributed over many components, and
requires systems data to describe the role of its individual players.
Therefore, data-driven (kinetic and stochastic) models of the
biochemical networks that govern G1/S and G2/S transitions, as
well as cell division have been developed to elucidate the cell
cycle control structure. However, these models should allow for
the understanding of how qualitative events (DNA replication
initiation and mitosis) result from quantitative (de)regulation of
cell cycle proteins in terms of their expression, subcellular
localization and dosage. Because of the large number and
complexity of the molecular interactions involved (feedback
regulations, interplay between gene regulation, post-
translational modiﬁcations, and localization), computer simula-
tions of well-parameterized models are essential to design
informative experiments. Such models should allow for a
systematic exploration of how protein dosage and dosage
imbalances within protein complexes impact phase transitions,
thereby elucidating the relevance of protein dynamics for timing
and duration of cell cycle switches. By incorporating realistic time
and dosage constraints–which are lacking in current models of cell
cycle regulation–it is possible to generate precise spatiotemporal
computer models.
An example of successful modeling approach able to integrate
quantitative information about gene dosage has been presented
for the investigation of biochemical mechanisms driving the
mammalian circadian clock.90 A computer model was proposed to
rationalize the early ﬁnding that stoichiometry between activators
and repressors, rather than their absolute levels, is crucial to
maintain a robust circadian rhythm.60 Speciﬁcally, the model is
able to show that the biochemical mechanism underlying
oscillations of the circadian clock relies on the stoichiometric
balance between activators and inhibitors. By varying the ratio
between circadian clock components, differences in circadian
rhythms between cell types were explained, and effects of
individual clock factor expression on circadian robustness were
predicted.
Putative interactions or protein co-dependencies may be
investigated by model simulations with altered dosage and/or
localization of two proteins simultaneously vs. model simulation of
the same proteins independently.47 The compartmentalization
aspect would yield hypotheses testable experimentally on the
quantitative importance of stoichiometry in protein complexes
and localization on the precise timing of cell cycle transitions, and
how these impact on the overall system robustness. These
properties cannot be captured in current cell cycle models, as
they currently do not include information about spatiotemporal
dynamics. The approach that we have proposed can result in an
increased model accuracy. Speciﬁcally, the modiﬁed models may
be interrogated for the effects (i) of simultaneous dosage variation
of partners within a protein complex, and (ii) on the phase
transition timing, which impact on cell cycle robustness. Strikingly,
in disease scenarios, these models may predict drug treatment
more accurately as compared to pure statistical models (for
example, it was suggested that pRB/p53 null tumors should not be
treated with inhibitors of DNA synthesis, but with Skp2 inhibitors,
to increase p27 levels86). Model predictions may subsequently be
tested by modifying mammalian cell lines to express two proteins
with a mutual dosage dependence, and comparing the dosage
threshold with cell lines containing only one single protein, akin to
the approach used in the yeast gTOW method to investigate
protein complex stoichiometry. If our proposed transient (plasmid)
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system is used, co-expression of the two proteins is realized by
using episomes with different ﬂuorescent reporters. When varying
the ratio of plasmid transfected, availability of either protein for
complex formation will be altered; by using two ﬂuorescent
reporters as readouts, information on the boundaries of protein
complex stoichiometry may be retrieved, as determined by
protein availability.
Thus, a systematic exploration of model predictions by using
quantitative data obtained employing the MAmTOW methodol-
ogy and localization studies, may result in focused disease
treatment strategies based on the understanding of the under-
lying process rather than on correlative deductions.
The Systems Biology strategy that we propose therefore
integrates computational and experimental challenges to inves-
tigate how protein dosage and localization of cell cycle molecules
affect temporal dynamics and robustness at the systems level. This
challenge may be realized practically by integrating well-
established computational frameworks (such as kinetic, stochastic
and/or Boolean models) and molecular map reconstruction with
the development and optimization of experimental efforts (Fig. 5).
Computer models, predicting how perturbed protein dosage and
localization impinge on cell cycle robustness, may serve as an
input for hypotheses, testable experimentally, of the extent by
which cell cycle robustness is maintained. Experimental testing
would not just be of support to the models, but is meant to
determine the endpoints of cell cycle perturbations; do these lead
to cell cycle arrest, apoptosis, or to potential pathological
conditions such as aneuploidy or abscission defects? Thus, the
blueprint (Fig. 5) requires integration of i) state-of-art molecular
tools, such as the CRISPR/Cas9 technology, that allow precise gene
replacements in mammalian cells, (ii) emerging, practically
realizable technologies to control gene expression in real-time,
such as the innovative MAmTOW methodology that we propose
here, and (iii) computational modeling and network analysis of a
curated molecular map, to compute robustness and determine
responsiveness quantitatively. This is pivotal to assess whether
and how alteration of the complexity of the cell cycle network,
inspected by removing interactions in silico, impacts on its
robustness against perturbations.
Fig. 4 Light-inducible localization of p27 to study alteration of cell division. a The p27 endogenous locus is engineered to include a
ﬂuorescent reporter (mCherry) and a LEXY light-inducible domain (visualized in blue). A small spacer (white box) is placed between the
CDKNB1 gene coding for p27 and the reporter/LEXY fusion. mCherry is used instead of GFP, as the latter is not compatible with the blue light
irradiation necessary to activate the LEXY domain. The engineered cells behave like wild type cells in the dark, but will delocalize p27 from the
nucleus when irradiated with blue light. The effects of non-nuclear p27 on timing of the G2/M transition, centrosome number and ploidy may
be evaluated. b Automated high-throughput ﬂuorescence microscopic analysis may be used in single cells to investigate (from left to right):
the upper expression limit of p27 (as well as of any cell cycle genes) by using the MAmTOW methodology; the impact of protein dosage and
localization on the cell’s phenotype, such as the number of centrosomes; and the impact of protein dosage and localization for protein
complex formation
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OUTLOOK
A key, yet elusive question in biology is: ‘Why are cellular networks
so complex?’ A possible answer may be that complexity is
required to lend cellular processes ﬂexibility to respond timely to a
variety of dynamic signals, while simultaneously warranting
robustness to protect cellular integrity against perturbations.
One example of such a biological process is the cell cycle. Some
mammalian cell types retain the ability to divide and, importantly,
do so continuously, whereas others require speciﬁc inputs to re-
enter the cell cycle. For example, upon terminal differentiation,
neurons typically halt cell division indeﬁnitely; however, this is not
due to a loss of the capability of cell division as, when stimulated
by the right cues, neurons can initiate the cell cycle, even when
undesired.91 Conversely, T-cells and hepatocytes are quiescent
until reception of immunological signals and after liver damage,
respectively, after which they promptly enter the cell cycle.92, 93
Yet other cell types, such as stem cells, important to the
development of the epidermis, cells of the hematopoietic system
and the intestine, retain somatic replicative capacity whereas their
differentiated counterparts loose this functionality.94 Importantly,
by supplying the known ‘Yamanaka factors’, even differentiated
cells can re-acquire pluripotent properties and, concomitantly,
increase proliferative capacity.95 Not only the cycling program, but
also the stimuli required to induce cell cycle entry and
proliferation, differ greatly among the aforementioned cell types,
which leads us to hypothesize a plasticity of cell cycle control.
Despite this impressive ﬂexibility in induction, the cell cycle
appears rather ‘rigid’, being tightly regulated: untimely stimuli for
proliferation may lead to halt cell division and, eventually, to
apoptosis. The existence of several molecular safeguards that act
upon reception of external stimuli guarantees halting; among
these safeguards, p27 is a pivotal player. Strikingly, in all of the
aforementioned cell types, e.g., neurons, T-cells, hepatocytes and
stem cells, this cyclin/Cdk inhibitor plays crucial roles.96–99 This
evidence suggests that dosage and spatiotemporal regulation of
this cell cycle regulator, among others, may critically determine
developmental states and cellular fates, such as pluripotency and
Fig. 5 Systems Biology blueprint to uncover new cell cycle functions. A framework that integrates computational and experimental analyses
is proposed to elucidate the impact of protein dosage, localization, and complex formation on temporal dynamics of cell cycle progression.
Literature analysis a allows for mapping of all molecules involved in the cell cycle network b, and assigning the directionality of their
connections. This information serves to generate cell cycle models c by employing alternative computational strategies (e.g., kinetic,
stochastic, Boolean) which rely on the spatiotemporal information for each molecule d. These models describe the behavior of molecules over
time e and will provide testable hypothesis, with a particular focus on how protein spatiotemporal dynamics may impact on cell cycle
robustness, progression and control. We expect these properties to emerge from the non-linear ensemble of molecules. The generated
hypotheses will be tested by employing a number of advanced expertimental technologies, and challenge them to: (i) investigate protein
relocalization and protein complex formation by light-induced technology and Fluorescence Correlation Spectroscopy, respectively f, and (ii)
investigate gene dosage by transient and stable (CRISPR/Cas9-based) MAmTOW methodology g. Furthermore, a variety of readouts may be
employed to measure gene dosage h, cell cycle phase distribution by FUCCI system i, DNA content j cytoplasmic and nuclear protein
distributions k, cellular ploidy l, and centrosome number m
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differentiation. Interestingly, a computer model that investigates
the effect of gene dosage for a robust circadian clock90 also
elaborates on the link between components of the clock and the
tumor-suppressor p53. Speciﬁcally, the computer model was able
to capture the observed experimental oscillations of Per2 and p53
only when protein localization was incorporated. As a number of
cell cycle components are regulated by p53, Per2 may link
circadian clock and cell cycle.5 In this context, regulation of p53-
mediated p27 stability through activation of the ubiquitin ligases
Pirh2 and KPC1 may provide a connection between the two
networks. Considering that deregulation of p53 as well as
modulation of p27 levels are implicated in cancer progression86,
it would be worthwhile to investigate this possible biochemical
mechanism by dedicated computer models that integrate dosage
constraints and spatiotemporal information.
Thus, the Systems Biology blueprint that we present here may
yield and improve diagnostic predictions, and forecast loss of
robustness in pathological disorders.
ACKNOWLEDGEMENTS
We thank Hans Westerhoff, Philipp Kaldis, Thomas Höfer and Hiroaki Kitano for
valuable discussions. This work was supported by the SILS Starting Grant of the
University of Amsterdam, UvA to M.B.
AUTHOR CONTRIBUTIONS
M.B. conceived the idea and the study, and designed the experimental strategies. M.
B. wrote the paper with contribution from P.V. P.V. helped with the ﬁnal layout of the
ﬁgures. M.B. provided scientiﬁc leadership and supervised the study.
ADDITIONAL INFORMATION
Supplementary Information accompanies the paper on the npj Systems Biology and
Applications website (http://doi.org/10.1038/s41540-017-0028-x).
Competing interests: M.B. wishes to share the information that a request for grant
of a patent for the “Maximum Allowable mammalian Trade–Off–Weight” (MAmTOW)
methodology has been submitted (patent application number GB1704645.9).
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims
in published maps and institutional afﬁliations.
REFERENCES
1. Cvijovic, M. et al. Bridging the gaps in systems biology. Mol. Genet. Genom. 289,
727–734 (2014).
2. Elowitz, M. B., Levine, A. J., Siggia, E. D. & Swain, P. S. Stochastic gene expression
in a single cell. Sci. Signal 297, 1183–1186 (2002).
3. Geva-Zatorsky, N. et al. Oscillations and variability in the p53 system. Mol. Syst.
Biol. 2, 2006.0033 (2006).
4. Crivellaro, S. et al. Non genomic loss of function of tumor suppressors in CML:
BCR-ABL promotes IκBα mediated p53 nuclear exclusion. Oncotarget 6,
25217–25225 (2015).
5. Gotoh, T. et al. Model-driven experimental approach reveals the complex reg-
ulatory distribution of p53 by the circadian factor Period 2. Proc. Natl Acad. Sci.
USA 113, 13516–13521 (2016).
6. Bartfeld, S. et al. High-throughput and single-cell imaging of NF-kappaB oscilla-
tions using monoclonal cell lines. BMC Cell Biol. 11, 21 (2010).
7. Kitano, H. Biological robustness. Nat. Rev. Genet. 5, 826–837 (2004).
8. Liang, J. et al. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and
opposes p27-mediated G1 arrest. Nat. Med. 8, 1153–1160 (2002).
9. Schlamp, C. L., Poulsen, G. L., Nork, T. M. & Nickells, R. W. Nuclear exclusion of
wild-type p53 in immortalized human retinoblastoma cells. J. Natl Cancer Inst. 89,
1530–1536 (1997).
10. Kim, J. et al. Cytoplasmic sequestration of p27 via AKT phosphorylation in renal
cell carcinoma. Clin. Cancer Res. 15, 81–90 (2009).
11. Serres, M. P. et al. Cytoplasmic p27 is oncogenic and cooperates with Ras both
in vivo and in vitro. Oncogene 30, 2846–2858 (2011).
12. Sharma, S. S., Ma, L., Bagui, T. K., Forinash, K. D. & Pledger, W. J. A p27Kip1 mutant
that does not inhibit CDK activity promotes centrosome ampliﬁcation and
micronucleation. Oncogene 31, 3989–3998 (2012).
13. Serres, M., Kossatz, U. & Chi, Y. p27Kip1 controls cytokinesis via the regulation of
citron kinase activation. J. Clin. Invest. 122, 844–858 (2012).
14. Pascreau, G., Churchill, M. E. & Maller, J. L. Centrosomal localization of cyclins E
and A: structural similarities and functional differences. Cell Cycle 10, 199–205
(2011).
15. Matsumoto, Y. & Maller, J. L. A centrosomal localization signal in cyclin E required
for Cdk2-independent S phase entry. Science 306, 885–888 (2004).
16. Ferguson, R. L., Pascreau, G. & Maller, J. L. The cyclin A centrosomal localization
sequence recruits MCM5 and Orc1 to regulate centrosome reduplication. J. Cell
Sci. 123, 2743–2749 (2010).
17. Pascreau, G., Eckerdt, F., Churchill, M. E. & Maller, J. L. Discovery of a distinct
domain in cyclin A sufﬁcient for centrosomal localization independently of Cdk
binding. Proc. Natl Acad. Sci. USA 107, 2932–2937 (2010).
18. Moore, J. D. In the wrong place at the wrong time: does cyclin mislocalization
drive oncogenic transformation? Nat. Rev. Cancer 13, 201–208 (2013).
19. Sivakumar, S. & Gorbsky, G. J. Spatiotemporal regulation of the anaphase-
promoting complex in mitosis. Nat. Rev. Mol. Cell Biol. 16, 82–94 (2015).
20. Kamenz, J., Mihaljev, T., Kubis, A., Legewie, S. & Hauf, S. Robust Ordering of
Anaphase Events by Adaptive Thresholds and Competing Degradation Pathways.
Mol. Cell 60, 446–459 (2015).
21. Alﬁeri, R. et al. Towards a systems biology approach to mammalian cell cycle:
modeling the entrance into S phase of quiescent ﬁbroblasts after serum stimu-
lation. BMC Bioinform. 10, S16 (2009).
22. Shaner, N. C., Steinbach, P. A. & Tsien, R. Y. A guide to choosing ﬂuorescent
proteins. Nat. Methods 2, 905–909 (2005).
23. Sander, J. D. & Joung, J. K. CRISPR-Cas systems for editing, regulating and tar-
geting genomes. Nat. Biotechnol. 32, 347–355 (2014).
24. Yang, H. et al. One-step generation of mice carrying reporter and conditional
alleles by CRISPR/Cas-mediated genome engineering. Cell 154, 1370–1379 (2013).
25. Gilbert, L. A. et al. CRISPR-mediated modular RNA-guided regulation of tran-
scription in eukaryotes. Cell 154, 442–451 (2013).
26. Rojas-Fernandez, A. et al. Rapid generation of endogenously driven transcrip-
tional reporters in cells through CRISPR/Cas9. Sci. Rep. 5, 9811 (2015).
27. Lo, C.-A. et al. Quantiﬁcation of Protein Levels in Single Living Cells. Cell Rep. 13,
2634–2644 (2015).
28. Sakaue-Sawano, A. et al. Visualizing spatiotemporal dynamics of multicellular cell-
cycle progression. Cell 132, 487–498 (2008).
29. Tada, S. Cdt1 and geminin: role during cell cycle progression and DNA damage in
higher eukaryotes. Front. Biosci. 12, 1629–1641 (2007).
30. Oki, T. et al. A novel cell-cycle-indicator, mVenus-p27K 2, identiﬁes quiescent cells
and visualizes G0–G1 transition. Sci. Rep. 4, 4012 (2014).
31. Russo, A. A., Jeffrey, P. D., Patten, A. K., Massagué, J. & Pavletich, N. P. Crystal
structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-
Cdk2 complex. Nature 382, 325–331 (1996).
32. Barberis, M. et al. The yeast cyclin-dependent kinase inhibitor Sic1 and mam-
malian p27Kip1 are functional homologues with a structurally conserved inhi-
bitory domain. Biochem. J. 387, 639–647 (2005).
33. Zielke, N. & Edgar, B. A. FUCCI sensors: powerful new tools for analysis of cell
proliferation. Wiley Interdiscip. Rev. Dev. Biol. 4, 469–487 (2015).
34. Sakaue-Sawano, A., Kobayashi, T., Ohtawa, K. & Miyawaki, A. Drug-induced cell
cycle modulation leading to cell-cycle arrest, nuclear mis-segregation, or
endoreplication. BMC Cell Biol. 12, 2 (2011).
35. Wang, X., Chen, X. & Yang, Y. Spatiotemporal control of gene expression by a
light-switchable transgene system. Nat. Methods 9, 266–269 (2012).
36. Müller, K. et al. A red/far-red light-responsive bi-stable toggle switch to control
gene expression in mammalian cells. Nucleic Acids Res. 41, e77 (2013).
37. Niopek, D. et al. Engineering light-inducible nuclear localization signals for pre-
cise spatiotemporal control of protein dynamics in living cells. Nat. Commun. 5,
4404 (2014).
38. Niopek, D., Wehler, P., Roensch, J., Eils, R. & Di Ventura, B. Optogenetic control of
nuclear protein export. Nat. Commun. 7, 10624 (2016).
39. Lindqvist, A., van Zon, W., Karlsson Rosenthal, C. & Wolthuis, R. M. Cyclin B1-Cdk1
activation continues after centrosome separation to control mitotic progression.
PLoS Biol. 5, e123 (2007).
40. Barberis, M., Klipp, E., Vanoni, M. & Alberghina, L. Cell size at S phase initiation: an
emergent property of the G1/S network. PLoS Comput. Biol. 3, e64 (2007).
41. Verbruggen, P. et al. Robustness of DNA repair through collective rate control.
PLoS Comput. Biol. 10, e1003438 (2014).
42. Wang, M. et al. PaxDb, a database of protein abundance averages across all three
domains of life. Mol. Cell. Proteom. 11, 492–500 (2012).
43. Zhu, H. & Mao, Y. Robustness of cell cycle control and ﬂexible orders of signaling
events. Sci. Rep. 5, 14627 (2015).
44. Csikász-Nagy, A., Battogtokh, D., Chen, K. C., Novák, B. & Tyson, J. J. Analysis of a
generic model of eukaryotic cell-cycle regulation. Biophys. J. 90, 4361–4379
(2006).
Systems-level quantitative cell cycle dynamics
M Barberis and P Verbruggen
13
Published in partnership with the Systems Biology Institute npj Systems Biology and Applications (2017)  26 
45. Adler, M., Mayo, A. & Alon, U. Logarithmic and power law input-output relations
in sensory systems with fold-change detection. PLoS Comput. Biol. 10, e1003781
(2014).
46. Goentoro, L. & Kirschner, M. W. Evidence that fold-change, and not absolute level,
of beta-catenin dictates Wnt signaling. Mol. Cell 36, 872–884 (2009).
47. Moriya, H., Shimizu-Yoshida, Y. & Kitano, H. In vivo robustness analysis
of cell division cycle genes in Saccharomyces cerevisiae. PLoS Genet. 2, e111
(2006).
48. Kaizu, K., Moriya, H. & Kitano, H. Fragilities caused by dosage imbalance in reg-
ulation of the budding yeast cell cycle. PLoS Genet. 6, e1000919 (2010).
49. Sasabe, M. et al. Evaluation of the lower protein limit in the budding yeast
Saccharomyces cerevisiae using TIPI-gTOW. BMC Syst. Biol. 8, 2 (2014).
50. Moriya, H., Chino, A., Kapuy, O., Csikász-Nagy, A. & Novák, B. Overexpression limits
of ﬁssion yeast cell-cycle regulators in vivo and in silico. Mol. Syst. Biol. 7, 556
(2011).
51. Clemente-Ruiz, M. et al. Gene Dosage Imbalance Contributes to Chromosomal
Instability-Induced Tumorigenesis. Dev. Cell 36, 290–302 (2016).
52. Harper, J. W. & Bennett, E. J. Proteome complexity and the forces that drive
proteome imbalance. Nature 537, 328–338 (2016).
53. Liu, Z., Lavis, L. D. & Betzig, E. Imaging Live-Cell Dynamics and Structure at the
Single-Molecule Level. Mol. Cell 58, 644–659 (2015).
54. Hink, M. A. Quantifying intracellular dynamics using ﬂuorescence ﬂuctuation
spectroscopy. Protoplasma 251, 307–316 (2014).
55. Wachsmuth, M. et al. High-throughput ﬂuorescence correlation spectroscopy
enables analysis of proteome dynamics in living cells. Nat. Biotechnol. 33,
384–389 (2015).
56. Fracassi, C., Postiglione, L., Fiore, G. & di Bernardo, D. Automatic Control of Gene
Expression in Mammalian Cells. ACS Synth. Biol. 5, 296–302 (2016).
57. D’Alessandro, M. et al. A tunable artiﬁcial circadian clock in clock-defective mice.
Nat. Commun. 6, 8587 (2015).
58. Chen, X. et al. Synthetic dual-input mammalian genetic circuits enable tunable
and stringent transcription control by chemical and light. Nucleic Acids Res. 44,
2677–2690 (2016).
59. Zhuang, C. et al. Tetracycline-inducible shRNA targeting long non-coding RNA
PVT1 inhibits cell growth and induces apoptosis in bladder cancer cells. Onco-
target 6, 41194–41203 (2015).
60. Lee, Y., Chen, R., Lee, H. M. & Lee, C. Stoichiometric relationship among clock
proteins determines robustness of circadian rhythms. J. Biol. Chem. 9, 7033–7042
(2011).
61. Chen, K. C. et al. Integrative Analysis of Cell Cycle Control in Budding Yeast. Mol.
Biol. Cell 15, 3841–3386 (2004).
62. Kaizu, K. et al. A comprehensive molecular interaction map of the budding yeast
cell cycle. Mol. Syst. Biol. 6, 41 (2010).
63. Alon, U. Network motifs: theory and experimental approaches. Nat. Rev. Genet. 8,
450–461 (2007).
64. Novák, B. & Tyson, J. J. Design principles of biochemical oscillators. Nat. Rev. Mol.
Cell Biol. 9, 981–991 (2008).
65. Ferrell, J. E. Jr. Feedback loops and reciprocal regulation: recurring motifs in the
systems biology of the cell cycle. Curr. Opin. Cell Biol. 25, 676–686 (2013).
66. Kawakami, E. et al. Network analyses based on comprehensive molecular inter-
action maps reveal robust control structures in yeast stress response pathways.
NPJ Syst. Biol. Appl. 2, 15018 (2016).
67. Linke, C. et al. A Clb/Cdk1-mediated regulation of Fkh2 synchronizes CLB
expression in the budding yeast cell cycle. NPJ Syst. Biol. Appl. 3, 7 (2017).
68. Kraikivski, P., Chen, K. C., Laomettachit, T., Murali, T. M. & Tyson, J. J. From START
to FINISH: computational analysis of cell cycle control in budding yeast. NPJ Syst.
Biol. Appl. 1, 15016 (2015).
69. Davidich, M. I. & Bornholdt, S. Boolean network model predicts cell cycle
sequence of ﬁssion yeast. PLoS One 3, e1672 (2008).
70. Li, F., Long, T., Lu, Y., Ouyang, Q. & Tang, C. The yeast cell-cycle network is
robustly designed. Proc. Natl Acad. Sci. USA 101, 4781–6 (2004).
71. Barberis, M., Todd, R. G. & van der Zee, L. Advances and challenges in logical
modeling of cell cycle regulation: perspective for multi-scale, integrative yeast
cell models. FEMS Yeast Res 17, 1–15 (2017).
72. Hong, C. et al. A checkpoints capturing timing-robust Boolean model of the
budding yeast cell cycle regulatory network. BMC Syst. Biol. 6, 129 (2012).
73. Qu, Z., Weiss, J. N. & MacLellan, W. R. Regulation of the mammalian cell cycle: a
model of the G1-to-S transition. Am. J. Physiol. Cell Physiol. 284, C349–C364
(2003).
74. Fauré, A., Naldi, A., Chaouiya, C. & Thieffry, D. Dynamical analysis of a generic
Boolean model for the control of the mammalian cell cycle. Bioinformatics 22,
e124–e131 (2006).
75. Gérard, C. & Goldbeter, A. Temporal self-organization of the cyclin/Cdk network
driving the mammalian cell cycle. Proc. Natl Acad. Sci. USA 106, 21643–21648
(2009).
76. Singhania, R., Sramkoski, R. M., Jacobberger, J. W. & Tyson, J. J. A hybrid model of
mammalian cell cycle regulation. PLoS Comput. Biol. 7, e1001077 (2011).
77. Barr, A. R., Heldt, F. S., Zhang, T., Bakal, C. & Novák, B. A Dynamical Framework for
the All-or-None G1/S Transition. Cell Syst. 2, 27–37 (2016).
78. Starostina, N. G. & Kipreos, E. T. Multiple degradation pathways regulate versatile
CIP/KIP CDK inhibitors. Trends Cell Biol. 22, 33–41 (2012).
79. Nakayama, K. et al. Mice lacking p27(Kip1) display increased body size, multiple
organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85, 707–720 (1996).
80. Kiyokawa, H. et al. Enhanced growth of mice lacking the cyclin-dependent kinase
inhibitor function of p27(Kip1). Cell 85, 721–732 (1996).
81. Fero, M. L. et al. A syndrome of multiorgan hyperplasia with features of gigant-
ism, tumorigenesis, and female sterility in p27(Kip1)-deﬁcient mice. Cell 85,
733–744 (1996).
82. Pagano, M. et al. Role of the ubiquitin–proteasome pathway in regulating
abundance of the cyclin‐dependent kinase inhibitor p27. Science 269, 682–685
(1995).
83. Nakayama, K. et al. Skp2-mediated degradation of p27 regulates progression into
mitosis. Dev. Cell 6, 661–672 (2004).
84. Nakayama, K. et al. Targeted disruption of Skp2 results in accumulation of cyclin E
and p27(Kip1), polyploidy and centrosome overduplication. EMBO J. 19,
2069–2081 (2000).
85. Chu, I. M., Hengst, L. & Slingerland, J. M. The Cdk inhibitor p27 in human cancer:
prognostic potential and relevance to anticancer therapy. Nat. Rev. Cancer 8,
253–267 (2008).
86. Zhao, H. et al. Skp2 deletion unmasks a p27 safeguard that blocks tumorigenesis
in the absence of pRb and p53 tumor suppressors. Cancer Cell 24, 645–659
(2013).
87. Wu, F. Y. et al. Reduction of cytosolic p27(Kip1) inhibits cancer cell motility,
survival, and tumorigenicity. Cancer Res. 66, 2162–2172 (2006).
88. Fabris, L. et al. p27kip1 controls H-Ras/MAPK activation and cell cycle entry via
modulation of MT stability. Proc. Natl Acad. Sci. USA 112, 13916–13921 (2015).
89. Sharma, S. S. & Pledger, W. J. The non-canonical functions of p27(Kip1) in normal
and tumor biology. Cell Cycle 15, 1189–1201 (2016).
90. Kim, J. K. & Forger, D. B. A mechanism for robust timekeeping via stoichiometric
balance. Mol. Syst. Biol. 8, 630 (2012).
91. Arendt, T. Cell cycle activation and aneuploid neurons in Alzheimer’s disease. Mol.
Neurobiol. 46, 125–135 (2012).
92. Guy, C. S. et al. Distinct TCR signaling pathways drive proliferation and cytokine
production in T cells. Nat. Immunol. 14, 262–270 (2013).
93. Berasain, C. & Avila, M. A. Regulation of hepatocyte identity and quiescence. Cell.
Mol. Life Sci. 72, 3831–3851 (2015).
94. Goodell, M. A., Nguyen, H. & Shroyer, N. Somatic stem cell heterogeneity: diversity
in the blood, skin and intestinal stem cell compartments. Nat. Rev. Mol. Cell Biol.
16, 299–309 (2015).
95. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse
embryonic and adult ﬁbroblast cultures by deﬁned factors. Cell 126, 663–676
(2006).
96. Godin, J. D. et al. p27(Kip1) is a microtubule-associated protein that promotes
microtubule polymerization during neuron migration. Dev. Cell 23, 729–744 (2012).
97. Wells, A. D. & Morawski, P. A. New roles for cyclin-dependent kinases in T cell
biology: linking cell division and differentiation. Nat. Rev. Immunol. 14, 261–270
(2014).
98. Ilyin, G. P., Glaise, D., Gilot, D., Baffet, G. & Guguen-Guillouzo, C. Regulation and
role of p21 and p27 cyclin-dependent kinase inhibitors during hepatocyte dif-
ferentiation and growth. Am. J. Physiol. Gastrointest. Liver Physiol. 285, G115–G127
(2003).
99. Walkley, C. R., Fero, M. L., Chien, W. M., Purton, L. E. & McArthur, G. A. Negative
cell-cycle regulators cooperatively control self-renewal and differentiation of
haematopoietic stem cells. Nat. Cell Biol. 7, 172–178 (2005).
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in anymedium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not included in the
article’s Creative Commons license and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly
from the copyright holder. To view a copy of this license, visit http://creativecommons.
org/licenses/by/4.0/.
© The Author(s) 2017
Systems-level quantitative cell cycle dynamics
M Barberis and P Verbruggen
14
npj Systems Biology and Applications (2017)  26 Published in partnership with the Systems Biology Institute
